<DOC>
	<DOCNO>NCT02150356</DOCNO>
	<brief_summary>Very study evaluate effect aleurone-enriched grain cardiovascular risk factor . Price et al . ( 2010 ) show 4-week supplementation aleurone-enriched product ( 27 g/day aleurone ) increase betaine concentration plasma whereas reduce homocysteine LDL-cholesterol level . Interestingly , aleurone effect total antioxidant status endothelial function , whereas improvement C-reactive protein observe ( Price RK et al , 2012 ) . It know whether consumption 27g/day aleurone-enriched product higher ferulic acid biodisponibility long time treatment could influence parameter individual metabolic syndrome . Noteworthy , study investigate effect aleurone-enriched product fast postprandial glycemic homeostasis lipid metabolism . In addition , mechanism aleurone may act vivo still unknown . The aim study investigate whether 8 week supplementation aleurone-enriched product may influence glucose lipid metabolism , incretin hormone level , satiety , inflammation , oxidative stress endothelial function overweight/obese subject high cardiovascular risk .</brief_summary>
	<brief_title>Effects Aleurone-enriched Products Cardiovascular Risk Factors</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<criteria>Overweight/obese subject gender Age range 20 70 year High cardiovascular metabolic risk profile enrol study Waist circumference &gt; 102 cm men , &gt; 88 cm woman At least one characteristic metabolic syndrome accord NCEP/ATP III criterion : Fasting triglyceride ≥150 mg/dl Highdensity lipoprotein cholesterol &lt; 40 mg/dl ( men ) / &lt; 50 mg/dl ( woman ) Blood pressure ≥ 130/85 mmHg Fasting glucose ≥100 mg/dl Age &lt; 20 &gt; 70 year Fasting triglyceride ≥400 mg/dl Fasting cholesterol &gt; 270 mg/dl Cardiovascular event ( myocardial infarction stroke ) 6 month prior study ; establish diabetes mellitus chronic disease Renal liver failure ( creatinine &gt; 1.7 mg/dl ALT/AST &gt; 2 time normal value , respectively ) Anaemia ( Hb &lt; 12 g /dl ) Any chronic disease People treat antihypertensive drug keep type dosage medication unchanged whole study period</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>